|Articles|April 1, 2017
- Pharmaceutical Executive-04-01-2017
- Volume 37
- Issue 4
Pharmaceutical Executive, April 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
HBA's Woman of the Year 2017about 9 years ago
Sales Force Effectiveness, Millennial Styleabout 9 years ago
The Lengthening Arm of Pharmacovigilanceabout 9 years ago
When Rare Becomes Commonabout 9 years ago
Advancing Rare Disease R&D: A Mission Updateabout 9 years ago
A Faster, More Flexible, and Frugal FDA?about 9 years ago
Country Report: GreeceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
4
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
5